ClearPoint Neuro (CLPT) Payables (2011 - 2026)

ClearPoint Neuro (CLPT) has 16 years of Payables data on file, last reported at $2.3 million in Q1 2026.

• For the quarter ending Q1 2026, Payables rose 91.61% year-over-year to $2.3 million; the trailing twelve-month figure through Mar 2026 stood at $2.3 million (up 91.61% YoY), and the FY2025 full-year result was $1.3 million, down 6.27% from the prior year.
• Payables improved to $2.3 million in Q1 2026, from $1.3 million in the prior quarter.
• In the past five years, Payables ranged from a high of $10.8 million in Q1 2024 to a low of $272000.0 in Q4 2022.
• A 5-year average of $2.3 million and a median of $1.3 million in 2023 frame the typical range for Payables.
• Across the five-year window, Payables jumped 748.47% in 2024 and tumbled 88.75% in 2025, its largest moves.
• Tracing CLPT's Payables over 5 years: stood at $272000.0 in 2022, then soared by 44.49% to $393000.0 in 2023, then surged by 240.97% to $1.3 million in 2024, then declined by 6.27% to $1.3 million in 2025, then jumped by 85.51% to $2.3 million in 2026.
• Business Quant data shows CLPT's Payables at $2.3 million in Q1 2026, $1.3 million in Q4 2025, and $723000.0 in Q3 2025.